Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study was made to evaluate the usefulness of various non-invasive methods such as electrocardiography, echocardiography and 201T1 myocardial scintigraphy in the differential diagnosis of idiopathic congestive cardiomyopathy (CCM) and
ischemic heart disease
(
IHD
). Eighteen cases with CCM and 9 cases with
IHD
were subjected. For this study patients with
IHD
showing dilated cavity (LVDd over 66 mm) and diffuse hypokinesis of the left ventricle in the echocardiogram were selected. For echocardiographic study, cross-sectional sector-scan instrument, Toshiba SSH-11A was used, and 201T1 myocardial scintigraphy was performed using Toshiba jumbo gamma camera
GCA
-401. Cardiothoracic ratio of CCM and
IHD
were 59.6 +/- 6.3% and 58.3 +/- 6.3% in average, respectively. In CCM, mean LVDd was 76.0 +/- 5.6 mm and mean LVDs was 63.4 +/- 7.3 mm. In
IHD
, mean LVDd was 74.7 +/- 8.1 mm and mean LVDs as 63.2 +/- 4.6 mm. Both cardiothoracic ratios and echocardiographic findings showed no difference between CCM and
IHD
. Incidence of an abnormal Q wave in ECG was higher in
IHD
(2.72 leads per a case) than that in CCM (1.33 leads per a case). An abnormal Q wave in aVL was frequently (28%) observed in CCM but none in
IHD
. However, these ECG findings did not seem to be contributory to the differential diagnosis. Myocardial scintigraphic study revealed that 10 of 18 cases with CCM showed no perfusion defect or sparse uptake and others showed small and isolated defect in the apex or postero-lateral wall of the left ventricle, while 7 of 9 cases with
IHD
showed large perfusion defect over 15% in the anterior and inferior areas. However, small localized defects less than 14% in the apex were observed in both groups, 5 cases (27.8%) with CCM, and 2 cases (22.2%) with
IHD
, suggesting limitation of this method for the differential diagnosis.
...
PMID:[Differential diagnosis of idiopathic congestive cardiomyopathy and ischemic heart disease by echocardiography and 201Tl-myocardial scintigraphy (author's transl)]. 734 20
Patients with different forms of systemic vasculitis experience long-term morbidity and mortality caused by cardiovascular disease due to premature atherosclerosis. Epidemiologic reports of patients with
GCA
suggest that long-term mortality in this disease is not increased compared with the general population of the same age. The risk of a stroke, however, in particular in the vertebrobasilar territory, is increased. In addition, the occurrence of aortic aneurysmal disease and aortic dissection is also clearly increased in
GCA
. Mortality due to
ischaemic heart disease
, however, is not increased. In Takayasu arteritis accelerated atherosclerosis has been clearly documented both clinically and in autopsy reports. Atherosclerotic plaques in the carotid artery may be present in the carotid arteries especially in patients with a documented history of arteritis involving the carotid artery. It is controversial whether Kawasaki disease is associated with accelerated atherosclerosis. Young adults with a history of Kawasaki disease may have abnormal brachial artery reactivity, increased carotid IMT values and increased arterial stiffness. At autopsy examinations of KD patients, however, no significant atherosclerotic lesions are detected and carotid IMT measurements were found to be clearly different from those in young adults with familiar hypercholesterolaemia, suggesting that the remodeling process in KD is different from atherosclerosis. In ANCA-associated vasculitis (AAV), an increased mortality as a consequence of cardiovascular disease is well-documented. In these patients the relative risk for coronary heart disease is two- to fourfold that in control subjects. In addition, a similar relative risk has been found for stroke. Diabetes, hypertension, dyslipidemia, abdominal obesity (metabolic syndrome), impaired renal function, persistent proteinuria and increased production of C-reactive protein are common risk factors for premature atherosclerosis in patients with systemic vasculitis. Furthermore, cholesterol and its modifications play a pivotal role in the pathogenesis of accelerated atherosclerosis in vasculitis. The (preventive) therapy for accelerated atherosclerosis in systemic vasculitis is based on an aggressive approach against inflammation and against risk factors of premature atherosclerosis such as smoking, inactivity, obesity and unhealthy diet. In addition, patients should be treated with angiotensin-converting enzyme inhibitors and/or angiotensin receptor-1 blockers for hypertension and statins for dyslipidemia. Finally, low dose acetylsalicylic acid should be prescribed in patients with large vessel vasculitis, i.e., both in
GCA
and TA, who do not have contraindications for ASA.
...
PMID:Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides. 2350 55
Giant coronary aneurysms (
GCA
with a diameter > 20 mm) are rare with a prevalence < 0.02%. A 62-year-old woman with no history of
ischaemic heart disease
was admitted to hospital with acute chest pain. A coronary angiography revealed a left an-terior descendent-associated
GCA
. A cardiac computed tomo-g-raphy demonstrated a "snake-pit"-like fistula connecting the
GCA
and the pulmonary artery. Atherosclerosis, connective tissue dis-orders, and previous coronary intervention will predispose to
GCA
. No evidence-based treatment regimen exists, but coiling, excision or a conservative approach, as in this case, is possible strategies.
...
PMID:[Fistula-producing giant coronary aneurysm in a 62-year-old woman]. 2549 15
Caloric restriction (CR) is a novel dietary therapy that has a protective effect on
myocardial ischemia
. However, the mechanisms underlying the therapeutic effect of CR remain unclear. Transfer RNA-derived small RNAs (tsRNAs) are a novel type of short non-coding RNAs that have potential regulatory functions in various physiological and pathological processes. In this study, we explored new therapeutic targets of CR through tsRNA sequencing. Rats were randomly divided into three groups: a normal control group (norm group), isoproterenol (ISO)-induced myocardial ischemic group (MI group), and CR pretreatment plus ISO-induced myocardial ischemic group (CR + MI group). Triphenyl tetrazolium chloride staining, terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, serum creatine kinase (CK) and lactic acid dehydrogenase activity detection kits, and creatine kinase isoenzyme 1 levels were used to measure the degree of myocardial ischemic injury. These indicators of
myocardial ischemia
were significantly improved in the CR + MI group compared with those in the MI group. In the ischemic myocardial tissue of the MI group, a total of 708 precisely matched tsRNAs were identified, and 302 tsRNAs (fold change >1.5,
P
< 0.05) were significantly changed when compared with those in the norm group. Furthermore, 55 tsRNAs were significantly regulated by CR pretreatment, among which five tsRNAs (tiRNA-His-GTG-004, tRF-Gly-TCC-018, tRF-Cys-
GCA
-022, tRF-Lys-CTT-026, tRF-Met-CAT-008) were randomly selected and verified by quantitative real-time polymerase chain reaction. In addition, predictions of target genes and bioinformatics analysis indicated that these tsRNAs may play a therapeutic role through the regulation of macromolecular metabolism. In conclusion, our findings reveal that tsRNAs are potential therapeutic targets for CR pre-pretreatment to improve myocardial ischemic injury. This study provides new ideas for future research on elucidating the mechanisms of CR pretreatment in ameliorating myocardial ischemic injury.
...
PMID:Systematic Analysis of tRNA-Derived Small RNAs Discloses New Therapeutic Targets of Caloric Restriction in Myocardial Ischemic Rats. 3322 44